1.
|
Phase: Phase III, Phase II Type: Supportive care Status: Temporarily closed Age: 18 to 65 Sponsor: Pharmaceutical / Industry Protocol IDs: CR-AIR-004, EudraCT no. 2008-008198-73, NCT00967343
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: Any age Sponsor: Other Protocol IDs: CRUK-EBV-CTL, LCMV-CTL, EU-20057, NCT00033475
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 to 60 Sponsor: NHLBI Protocol IDs: NHLBI-98-H-0006, NCT00003552
|
|
4.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 75 and under Sponsor: NCI, Other Protocol IDs: 1655.00, NCI-2009-01471, P01CA018029, FHCRC-1655.00, 5430, NCT00052520
|
|
5.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: Any age Sponsor: NCI, Other Protocol IDs: 1803.00, NCI-2010-00163, P01CA078902, FHCRC-1803.00, 5606, NCT00068718
|
|
6.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 to 60 Sponsor: NCI Protocol IDs: CALGB-100102, NCT00085449
|
|
7.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: FHCRC-1135.00
|
|
8.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 to 70 Sponsor: Other Protocol IDs: 2004LS042, UMN-MT2003-23, UMN-IRB-0405M60481, UMN-2004LS042, NCT00303667
|
|
9.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 to 65 Sponsor: Other, Pharmaceutical / Industry Protocol IDs: GCLLSG-CLL3X, EU-20554, MEDAC-FLUD.10/CLL, NCT00281983
|
|
10.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 to 55 Sponsor: NCI, Other Protocol IDs: LCCC 0510, P30CA016086, CDR0000550145, UNC-LCCC-0510, NCT00448357
|
|
11.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ITL-001-HM, NCT00861965
|
|
12.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: 1380.00, FHCRC-1380.00, NCI-H00-0057, CDR0000067777, NCT00005802
|
|
13.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: Under 75 Sponsor: NCI, Other Protocol IDs: 1495.00, NCI-2012-00581, FHCRC-1495.00, NCI-G00-1790, NCT00005851
|
|
14.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: Under 75 Sponsor: NCI, Other Protocol IDs: 1533.00, FHCRC-1533.00, NCI-H00-0062, CDR0000068184, NCT00006251
|
|
15.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 75 and under Sponsor: NCI, Other Protocol IDs: 1586.00, FHCRC-1586.00, NCI-H01-0080, CDR0000069042, NCT00027547
|
|
16.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: Any age Sponsor: NCI, Other Protocol IDs: 1641.00, NCI-2012-00591, P01CA018029, P01HL036444, FHCRC-1641.00, NCI-H01-0081, NCT00027820
|
|
17.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 to 70 Sponsor: NCI, Other Protocol IDs: 1743.00, NCI-2011-00386, P01CA078902, FHCRC-1743.00, 5476, NCT00054353
|
|
18.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 to 69 Sponsor: Other Protocol IDs: 1838.00, FHCRC-1838.00, CDR0000430694, NCT00248430
|
|
19.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: ECOG-E1A97, E1A97, NCT00003153
|
|
20.
|
Phase: Phase II Type: Treatment Status: Closed Age: 10 to 80 Sponsor: NHLBI Protocol IDs: NHLBI-99-H-0064, NCT00003839
|
|
21.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: CDR0000067365, UCCRC-9672, UCCRC-CTRC-9866, NCI-G99-1612, NCT00004135
|
|
22.
|
Phase: Phase II Type: Treatment Status: Closed Age: Over 55 to under 75 Sponsor: NCI Protocol IDs: UCHSC-00119, FHCRC-1406.00, NCI-G00-1778, NCT00005801
|
|
23.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 to 70 Sponsor: NCI Protocol IDs: NCI-00-C-0119, NCI-1027, NCT00020176
|
|
24.
|
Phase: Phase II Type: Treatment Status: Closed Age: Under 70 Sponsor: NCI, Other Protocol IDs: CDR0000068185, U10CA031946, CALGB-109901, NCT00006252
|
|
25.
|
Phase: Phase II Type: Treatment Status: Closed Age: Over 18 Sponsor: Other Protocol IDs: MSGCC-0012, NCI-V00-1624, NCT00006350
|